- Telehealth visits
Greta Peng, MD
Pediatric Neurology- Telehealth visits
On this page
About me
Dr. Greta Peng is a pediatric neurologist who specializes in caring for children and young adults with brain, spinal, or peripheral nerve tumors. She is committed to working collaboratively with each patient's entire care team as well as to providing access to clinical trials (studies of promising new treatments). She also has a special interest in treating neurofibromatosis type I (a condition that predisposes a person to nervous system tumors) as well as neurologic complications of pediatric cancers.
In her research, Peng focuses on improving quality of life for children with brain tumors. She looks especially at how the health care system can better support families of diverse backgrounds.
Peng earned her medical degree at the Warren Alpert Medical School of Brown University. At UCSF, she completed a residency in pediatric neurology and a fellowship in pediatric neuro-oncology.
Outside of work, Peng enjoys spending time with her husband and son.
Education & training
Board certification
- Neurology w/ Special Qualification in Child Neurology - General, American Board of Medical Specialties
Residency
- Pediatric Neurology, UCSF School of Medicine -GME
Internship
- Pediatrics, UCSF School of Medicine -GME
Degree
- MD, Warren Alpert Medical School of Brown University
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
An Opus Like No Other.Opens in a new window
June 26, 2022
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.